Original Article

You have free access to this content

Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients

A retrospective, single-institution study

  1. John M. Granger MD, MPH,
  2. Dimitrios P. Kontoyiannis MD, ScD†,*

Article first published online: 23 JUN 2009

DOI: 10.1002/cncr.24480

Issue

Cancer

Cancer

Volume 115, Issue 17, pages 3919–3923, 1 September 2009

Additional Information

How to Cite

Granger, J. M. and Kontoyiannis, D. P. (2009), Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients. Cancer, 115: 3919–3923. doi: 10.1002/cncr.24480

Author Information

  1. Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  1. †

    Fax: (713) 745-6839

*Department of Infectious Diseases, Infection Control and Employee Health, Unit 402, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030

Publication History

  1. Issue published online: 20 AUG 2009
  2. Article first published online: 23 JUN 2009
  3. Manuscript Accepted: 5 FEB 2009
  4. Manuscript Revised: 23 JAN 2009
  5. Manuscript Received: 2 DEC 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (120K)

References

  • 1
    McKee LC Jr. Excess leukocytosis (leukemoid reactions) associated with malignant diseases. South Med J. 1985; 78: 1475–1482.
  • 2
    Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Giamarellou H. An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med. 2006; 17: 394–398.
  • 3
    Schniewind B, Christgen M, Hauschild A, Kurdow R, Kalthoff H, Klomp HJ. Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: establishment of KT293, a novel G-CSF-secreting melanoma cell line. Cancer Biol Ther. 2005; 4: 23–27.
  • 4
    Kojima K, Nakashima F, Boku A, Muroishi Y, Nakanishi I, Oda Y. Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis. Histol Histopathol. 2002; 17: 1005–1016.
  • 5
    Azuma T, Sakai I, Matsumoto T, et al. Leukemoid reaction in association with bone marrow necrosis due to metastatic prostate cancer. Intern Med. 2005; 44: 1093–1096.
  • 6
    Sato K, Fujii Y, Ono M, Nomura H, Shizume K. Production of interleukin 1 alpha-like factor and colony-simulating factor by a squamous cell carcinoma of the thyroid (T3M-5) derived from a patient with a hypercalcemia and leukocytosis. Cancer Res. 1987; 47: 6474–6480.
  • 7
    Cvitkovic E, Bachouchi M, Boussen H, et al. Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases. J Clin Oncol. 1993; 11: 2434–2442.
  • 8
    Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer. 2001; 92: 2399–2405.
    Direct Link:
  • 9
    Nasser SM, Choudry UH, Nielsen GP, Ott MJ. A leukemoid reaction in a patient with a dedifferentiated liposarcoma. Surgery. 2001; 129: 765–767.
  • 10
    Watanabe M, Katsuaki O, Ozeki Y, Tanaka S, Aida S, Okuno Y. Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma. Jpn J Clin Oncol. 1998; 28: 559–562.
  • 11
    Wetzler M, Estrov Z, Talpaz M, Markowitz A, Gutterman JU, Kurzrock R. Granulocyte-macrophage colony-stimulating factor as a cause of paraneoplastic leukaemoid reaction in advanced transitional cell carcinoma. J Intern Med. 1993; 234: 417–420.
    Direct Link:
  • 12
    Qureshi KM, Raman AK, Tan D, Fakih MG. Leukemoid reaction in pancreatic cancer: a case report and review of the literature. JOP. 2006; 7: 631–634.
  • 13
    Asano S, Urabe A, Okabe T, Sato N, Kondo Y. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood. 1977; 49: 845–852.
  • 14
    Lee MY, Kaushansky K, Judkins SA, Lottsfeldt JL, Waheed A, Shadduck RK. Mechanism of tumor-induced neutrophilia: constitutive production of colony-stimulating factors and their synergistic actions. Blood. 1989; 74: 115–122.
  • 15
    Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004; 4: 540–550.
  • 16
    Berdel WE, Danhauser-Riedl S, Steinhauser G, Winton EF. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood. 1989; 74: 1446–1447.
  • 17
    Saussez S, Heimann P, Vandevelde L, et al. Undifferentiated carcinoma of the nasopharynx and leukemoid reaction: report of case with literature review. J Laryngol Otol. 1997; 111: 66–69.
  • 18
    Jardin F, Vasse M, Debled M, et al. Intense paraneoplastic neutrophilic leukemoid reaction related to a G-CSF-secreting lung sarcoma. Am J Hematol. 2005; 80: 243–245.
    Direct Link:
  • 19
    Kitamura H, Kodama F, Odagiri S, Nagahara N, Inoue T, Kanisawa M. Granulocytosis associated with malignant neoplasms: a clinicopathologic study and demonstration of colony-stimulating activity in tumor extracts. Hum Pathol. 1989; 20: 878–885.
View Full Article (HTML) Get PDF (120K)